A multidisciplinary panel discusses the effects of GLP-1 RA use during breast cancer care along with insurance denials, costs, and other critical areas.
Emily M. Beard, RN, BSN, OCN, CBCN
Advertisement
Articles by Emily M. Beard, RN, BSN, OCN, CBCN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Divarasib Improves Survival vs Sotorasib or Adagrasib in KRAS G12C+ NSCLC
2
Ivonescimab Combo Improves Survival in Advanced Biliary Tract Cancer
3
Osimertinib/Savolitinib Improves Survival in MET-Altered EGFR-Mutant NSCLC
4
Sonesitatug Vedotin Improves OS in Pretreated CLDN18.2+ Gastroesophageal Cancer
5